Abingworth Exceeds Target on Latest Life-Sciences Fund

U.K. life-sciences investor Abingworth said it has closed a new fund with $315 million. The vehicle, Abingworth Bioventures VII LP, exceeded its $300 million target. Placement agent Asante Capital Group helped raise the fund. Abingworth has invested in more than 145 life-sciences companies and raised 12 life-sciences funds since its founding in 1973.

READ FULL ARTICLE ON WSJ PRO

jpeg 22

Other News

            

Asian Firm Longreach Spanned Globe to Raise New Fund

2/04/2019

The private-equity firm, which is based in Tokyo and focused on buyouts and corporate carve-outs in Japan, closed Longreach Capital Partners 3 LP at its $650 million target. That represents a 63% increase from the $400 million the firm collected for its previous vehicle in 2012. READ FULL ARTICLE ON WSJ PRO

READ FULL ARTICLE >

Private Equity Wire Award Winners 2019

11/03/2019

Asante Capital was awarded Best Firm for Fund Advisory (Placement) 2019. The Private Equity Wire Awards, presented in London, recognise the best private equity managers, investors, consultants, advisers and service providers during 2018. All votes were determined by the readers of Private Equity Wire.

READ FULL ARTICLE >

Asante 2018 Global Market Survey

18/12/2018

2018 proved to be another remarkable year for the private markets as fundraising numbers broke previous records – further evidence that the balloon is now nearing the stratosphere and it’s a long way down! We hope you enjoy it on our LinkedIn profile. Whilst you’re at it, if you get a chance to cast your […]

READ FULL ARTICLE >